Up More than 19% In 2022, Is Gilead Sciences Still a Buy?

Published on December 20, 2022

Gilead Sciences (GILD) beat revenue and earnings estimates in the previous quarter and upgraded its guidance for fiscal 2022. Having risen more than 19% year-to-date, is GILD still a buy?...

Continue reading on website
Other news

Bear Market is Back Again…

December 20, 2022
A lot has happened since my stock market (SPY) commentary last week! We nailed the interest rate hike — 50 bps, as everyone expected — and I was right that...

Virtual Dining Concepts CEO Stephanie Sollers on the Creator Economy

December 20, 2022
Interview with CEO of Virtual Dining Concepts Stephanie Sollers about branding and marketing in the creator economy, the importance of storytelling, and working with Mr. Beast, Faze Clan, and other icons.